Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV
Pharma
MSF decries Gilead's updated global access plan for Yeztugo
Gilead expanded its commitment to bring Yeztugo to 3 million people worldwide, but MSF says supply is still "not nearly enough."
Zoey Becker
Apr 15, 2026 12:14pm
ViiV Healthcare launches ‘Still Here’ HIV campaign
Apr 13, 2026 8:47am
Manufacturing is key to Gilead's Yeztugo PrEP rollout: exec
Mar 13, 2026 10:33am
GSK props up its Cabenuva in adolescents with long-term data
Feb 26, 2026 1:00pm
Gilead further pads case for single-tablet HIV med
Feb 25, 2026 1:50pm
Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B
Jan 20, 2026 10:15am
